Digestant drugs

B. Loretz et al. Oral gene delivery strategies to improve stability of pDNA towards intestinal digestion. /. Drug Target, 14(5), 311-319 (2006). 

Candidate protease inhibitor drugs must be relatively specific for the HIV-1 protease. Many other aspartic proteases exist in the human body and are essential to a variety of body functions, including digestion of food and processing of hormones. An ideal drug thus must strongly inhibit the HIV-1 protease, must be delivered effectively to the lymphocytes where the protease must be blocked, and should not adversely affect the activities of the essential human aspartic proteases. 

Antiflatulents are used for die relief of painful symptoms of excess gas in the digestive tract. These drugs are useful as adjunctive treatment of any condition in which gas retention may be a problem (ie, postoperative gaseous distention, air swallowing, dyspepsia, peptic ulcer, irritable colon, or diverticulosis). In addition to its use for tiie relief of intestinal gas, charcoal may be used in the prevention of nonspecific pruritus associated with kidney dialysis treatment and as an antidote in poisoning. Simethicone is in some antacid products, such as Mylanta liquid and Di-Gel liquid. 

These drug are prescribed as replacement therapy for those with pancreatic enzyme insufficiency. Conditions or diseases that may cause a decrease in or absence of pancreatic digestive enzymes include cystic fibrosis, chronic pancreatitis, cancer of the pancreas,... 

D Diarrhea related to adverse reactions ot magnesium- or sodium-containing antadds or other digestive system drugs... 

The administration of drugs to ease disease and chronic, severe pain or to provide benefits such as hormone replacement therapy is difficult because drugs taken orally may lose much of their potency in the harsh conditions of the digestive system. In addition, they are distributed throughout the entire body, not just where they are needed, and side effects can be significant. Recently, however, techniques have been developed to deliver drugs gradually over time, to the exact location in the body where they are needed, and even at the time when they are needed. 

Sagir A, Schmitt M, Dilger K, Haussinger D (2003) Inhibition of cytochrome P450 3A relevant drug interactions in gastroenterology. Digestion 68 41 8... 

---